Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boglarka Gyurkocza

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Transplantation and Cellular Therapy|October 9, 2025
Salvage Allogeneic Hematopoietic Cell Transplantation for Primary Graft FailureBoglarka Gyurkocza, Brenda M Sandmaier
Current Opinion in Hematology|January 9, 2020
Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemiaAlexandra Gomez-Arteaga, Boglarka Gyurkocza
Blood|June 11, 2014
Conditioning regimens for hematopoietic cell transplantation: one size does not fit allBoglarka Gyurkocza, Brenda M Sandmaier
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2011
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantationBoglarka Gyurkocza, Frederick R Appelbaum
Blood Reviews|September 18, 2012
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?Boglarka Gyurkocza, H Joachim Deeg
Expert Review of Hematology|September 28, 2010
Allogeneic hematopoietic cell transplantation: the state of the artBoglarka Gyurkocza, Andrew Rezvani, Rainer F Storb
Cancer|September 20, 2011
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantationMin Fang, Barry Storer, Brent Wood, et al.
Leukemia & Lymphoma|January 23, 2019
Second allogeneic hematopoietic cell transplantation for relapse after first allograftsBoglarka Gyurkocza, Rainer Storb, Thomas R Chauncey, et al.
Transplantation|June 24, 2003
Tolerance and chimerismHans-Jochem Kolb, Wolfgang Guenther, Boglarka Gyurkocza, et al.
Case Reports in Hematology|September 9, 2024
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell TransplantationMary Nauffal, Stephen Eng, Andrew Lin, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|October 9, 2025
Salvage Allogeneic Hematopoietic Cell Transplantation for Primary Graft FailureBoglarka Gyurkocza, Brenda M Sandmaier
Current Opinion in Hematology|January 9, 2020
Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemiaAlexandra Gomez-Arteaga, Boglarka Gyurkocza
Blood|June 11, 2014
Conditioning regimens for hematopoietic cell transplantation: one size does not fit allBoglarka Gyurkocza, Brenda M Sandmaier
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2011
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantationBoglarka Gyurkocza, Frederick R Appelbaum
Blood Reviews|September 18, 2012
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?Boglarka Gyurkocza, H Joachim Deeg
Expert Review of Hematology|September 28, 2010
Allogeneic hematopoietic cell transplantation: the state of the artBoglarka Gyurkocza, Andrew Rezvani, Rainer F Storb
Cancer|September 20, 2011
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantationMin Fang, Barry Storer, Brent Wood, et al.
Leukemia & Lymphoma|January 23, 2019
Second allogeneic hematopoietic cell transplantation for relapse after first allograftsBoglarka Gyurkocza, Rainer Storb, Thomas R Chauncey, et al.
Transplantation|June 24, 2003
Tolerance and chimerismHans-Jochem Kolb, Wolfgang Guenther, Boglarka Gyurkocza, et al.
Case Reports in Hematology|September 9, 2024
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell TransplantationMary Nauffal, Stephen Eng, Andrew Lin, et al.
Pageof 8